Knott David M Jr Avadel Pharmaceuticals PLC Transaction History
Knott David M Jr
- $285 Million
- Q3 2024
A detailed history of Knott David M Jr transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Knott David M Jr holds 332,000 shares of AVDL stock, worth $3.4 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
332,000
Previous 333,000
0.3%
Holding current value
$3.4 Million
Previous $4.68 Million
7.01%
% of portfolio
1.53%
Previous 1.87%
Shares
11 transactions
Others Institutions Holding AVDL
# of Institutions
8Shares Held
1.07MCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL600KShares$6.14 Million3.88% of portfolio
-
Schulhoff & CO Inc137KShares$1.4 Million0.81% of portfolio
-
1620 Investment Advisors, Inc. Plymouth, MA1KShares$10,2300.01% of portfolio
-
American Portfolios Advisors Holbrook, NY500Shares$5,1150.0% of portfolio
-
American Research & Management Co.100Shares$1,0230.0% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $620M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...